Betnor E/E Drop
Beclomethasone + Neomycin Topical
DCI Pharmaceuticals Pvt. Ltd.
| Pack size | |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 57.20 NPR |
Indications
Betnor E/E Drop is used for:
Bacterial skin infection with inflammatory condition
Adult Dose
Topical
Apply cream/ointment bid or tid for 7 days.
Child Dose
Safety and efficacy not established
Renal Dose
Administration
Contra Indications
Hypersensitivity
Precautions
For external use only
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Beclomethasone + Neomycin Topical :
Skin sensitization,Burning,Itching,Irritation,Dryness,Folliculitis,Hypertrichosis,Acneiform eruptions,Hypopigmentation,Perioral dermatitis,Allergic contact dermatitis,Maceration of the skin,Secondary infection,Skin atrophy
Striae,Miliaria
Mechanism of Action
Beclometasone controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes, fibroblasts, reverses capillary permeability and lysosomal stabilisation at the cellular level to prevent or control inflammation.
Neomycin interferes w/ bacterial protein synthesis by binding to 30S ribosomal subunits.
Note
Betnor E/E Drop manufactured by DCI Pharmaceuticals Pvt. Ltd.. Its generic name is Beclomethasone + Neomycin Topical. Betnor is availble in Nepal.
Farmaco Nepal drug index information on Betnor E/E Drop is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.